Cost-effectiveness of folic acid therapy for primary prevention of stroke in patients with hypertension

被引：0

作者：

Tiantian Zhang

Zhuoru Liang

Tengfei Lin

David J. Cohen

Alejandro Arrieta

Xiaobin Wang

Xianhui Qin

Binyan Wang

Yong Huo

Gordon G. Liu

Jie Jiang

Zugui Zhang

机构：

[1] Jinan University,College of Pharmacy/International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Ministry of Education (MOE) of China

[2] Guangzhou Huabo Biopharmaceutical Research Institute,Department of Pharmacy

[3] The Third Affiliated Hospital (The Affiliated Luohu Hospital) of Shenzhen University,Department of Health Policy and Management, Robert Stempel College of Public Health and Social Work

[4] Guangzhou Institutes of Biomedicine and Health,Department of Population, Family and Reproductive Health

[5] Chinese Academy of Sciences,National Clinical Research Study Center for Kidney Disease, The State Key Laboratory for Organ Failure Research, Renal Division, Nanfang Hospital

[6] Shenzhen Institutes of Advanced Technology,Department of Cardiology

[7] Chinese Academy of Sciences,National School of Development

[8] Cardiovascular Research Foundation,undefined

[9] St. Francis Hospital,undefined

[10] Florida International University,undefined

[11] Johns Hopkins University Bloomberg School of Public Health,undefined

[12] Southern Medical University,undefined

[13] Shenzhen Evergreen Medical Institute,undefined

[14] Institute of Biomedicine,undefined

[15] Anhui Medical University,undefined

[16] Peking University First Hospital,undefined

[17] Peking University,undefined

[18] Institute for Global Health and Development,undefined

[19] Peking University,undefined

[20] Institute for Research in Equity and Community Health,undefined

[21] Christiana Care Health System,undefined

来源：

BMC Medicine | / 20卷

关键词：

Cost-effectiveness; Folic acid; Primary prevention; Stroke; Hypertension;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 240 条

[1]

Roth GA(2020)Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study J Am Coll Cardiol 76 2982-3021

[2]

Mensah GA(2020)Heart Disease and Stroke Statistics-2020 update: a report from the American Heart Association Circulation 141 e139-e596

[3]

Johnson CO(2010)Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial BMJ 341 c6273-1577

[4]

Addolorato G(2006)Homocysteine lowering with folic acid and B vitamins in vascular disease N Engl J Med 354 1567-1882

[5]

Ammirati E(2007)Efficacy of folic acid supplementation in stroke prevention: a meta-analysis Lancet 369 1876-1335

[6]

Baddour LM(2015)Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial JAMA 313 1325-2143

[7]

Barengo NC(2017)A meta-analysis of folic acid in combination with anti-hypertension drugs in patients with hypertension and hyperhomocysteinemia Front Pharmacol 8 585-464

[8]

Beaton AZ(2012)Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010 Lancet 380 2129-247

[9]

Benjamin EJ(2007)Stroke in China: epidemiology, prevention, and management strategies Lancet Neurol 6 456-153

[10]

Benziger CP(2015)Cost-effectiveness of statin treatment for primary prevention in conditions of real-world adherence--estimates from the Finnish prescription register Atherosclerosis 239 240-197

← 1 2 3 4 5 6 7 8 9 10 →